Literature DB >> 16786463

[New aspects of atrial fibrillation therapy].

U Ravens, D Dobrev, A Goette.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16786463     DOI： 10.1007/s00399-006-0511-3

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN： 0938-7412


× No keyword cloud information.
  12 in total

1.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse
Journal:  Eur Heart J       Date:  2001-10       Impact factor: 29.983

Review 2.  [New antiarrhythmic drugs for therapy of atrial fibrillation: II. Non-ion channel blockers].

Authors:  M Hammwöhner; A D'Alessandro; D Dobrev; P Kirchhof; A Goette
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006-06

Review 3.  New ideas about atrial fibrillation 50 years on.

Authors:  Stanley Nattel
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

4.  Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation.

Authors:  A Goette; T Staack; C Röcken; M Arndt; J C Geller; C Huth; S Ansorge; H U Klein; U Lendeckel
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

5.  Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans.

Authors:  A Goette; M Arndt; C Röcken; A Spiess; T Staack; J C Geller; C Huth; S Ansorge; H U Klein; U Lendeckel
Journal:  Circulation       Date:  2000-06-13       Impact factor: 29.690

Review 6.  [Anticoagulation with atrial fibrillation].

Authors:  S Zellerhoff; A Goette; P Kirchhof
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006-06

Review 7.  [Genetics of atrial fibrillation: rare mutations, common variants and clinical relevance?].

Authors:  M F Sinner; A Pfeufer; S Kääb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006-06

8.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.

Authors:  M Haïssaguerre; P Jaïs; D C Shah; A Takahashi; M Hocini; G Quiniou; S Garrigue; A Le Mouroux; P Le Métayer; J Clémenty
Journal:  N Engl J Med       Date:  1998-09-03       Impact factor: 91.245

Review 9.  Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.

Authors:  Stanley G Rockson; Gregory W Albers
Journal:  J Am Coll Cardiol       Date:  2004-03-17       Impact factor: 24.094

Review 10.  Electrical, contractile and structural remodeling during atrial fibrillation.

Authors:  Maurits Allessie; Jannie Ausma; Ulrich Schotten
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787
View more
  1 in total

1.  Advances in cardiac cellular electrophysiology - Relevance for clinical translation.

Authors:  Ursula Ravens; Andreas Goette
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.